Patent Assignment
Reel/Frame 044956/0868
Change of Name
Recorded: 2017-12-20
Pages: 4
Assignor
ANGIOBLAST SYSTEMS, INC.
Executed: 2011-09-30
Assignee
MESOBLAST, INC.
275 MADISON AVE, 4TH FLOOR, NEW YORK, NEW YORK, 10016
Covered Properties
(2)
Method for Treating Diabetic Renal Failure or Syndrome X
Method for Treating or Preventing a Pancreatic Dysfunction
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 20, 2017
From: ITESCU, SILVIU; KRISHNAN, RAVI
To: ANGIOBLAST SYSTEMS, INC.
Reel/Frame 044451/0858 →
Intellectual Property Security Agreement
Mar 28, 2018
From: MESOBLAST, INC.
To: HERCULES CAPITAL, INC., AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 045759/0682 →
Security Interest
Dec 10, 2021
From: MESOBLAST LIMITED ACN 109 431 870; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 058957/0447 →
Release of Intellectual Property Security Agreement at Reel/Frame No. 45759/0682
Jul 30, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: MESOBLAST, INC.
Reel/Frame 072294/0555 →
Release of Security Interest in Intellectual Property
Jan 2, 2026
From: OAKTREE FUND ADMINISTRATION, LLC, AS AGENT
To: MESOBLAST LIMITED; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 074174/0183 →